He, Funan http://orcid.org/0000-0002-4592-4034
Bandyopadhyay, Abhik M.
Klesse, Laura J. http://orcid.org/0000-0003-1323-7720
Rogojina, Anna
Chun, Sang H.
Butler, Erin
Hartshorne, Taylor http://orcid.org/0009-0009-2036-9757
Holland, Trevor
Garcia, Dawn
Weldon, Korri
Prado, Luz-Nereida Perez
Langevin, Anne-Marie
Grimes, Allison C.
Sugalski, Aaron
Shah, Shafqat
Assanasen, Chatchawin
Lai, Zhao
Zou, Yi
Kurmashev, Dias
Xu, Lin http://orcid.org/0000-0001-5815-4457
Xie, Yang
Chen, Yidong
Wang, Xiaojing http://orcid.org/0000-0002-2631-4708
Tomlinson, Gail E.
Skapek, Stephen X.
Houghton, Peter J.
Kurmasheva, Raushan T. http://orcid.org/0000-0003-3212-2363
Zheng, Siyuan http://orcid.org/0000-0002-1031-9424
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP160716, RP180319)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R50CA265339, P30CA054174)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 29 March 2023
Accepted: 7 November 2023
First Online: 22 November 2023
Competing interests
: L.J.K. consults for Alexion Pharmaceuticals without a fee. The other authors declare no competing interests.